Inhibition of polyamine biosynthesis, EIF5A hypusination, or c-Myc suppressed vemurafenib resistance in melanoma cell line models with either acquired or intrinsic resistance against BRAF inhibitors both in vitro and in vivo. This evidence concerns the gene BRAF and melanoma.